NIOX Group (LON:NIOX) Trading Down 0.6% – What’s Next?

NIOX Group Plc (LON:NIOX)’s stock price dropped 0.6% during mid-day trading on Wednesday . The company traded as low as GBX 66.20 and last traded at GBX 67.20. Approximately 604,052 shares traded hands during trading, a decline of 38% from the average daily volume of 967,638 shares. The stock had previously closed at GBX 67.60.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reduced their target price on NIOX Group from GBX 90 to GBX 86 and set a “buy” rating for the company in a report on Wednesday, January 21st. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of GBX 88.

NIOX Group Stock Performance

The company’s 50-day moving average is GBX 67.65 and its two-hundred day moving average is GBX 69.99. The company has a market capitalization of £275.24 million, a P/E ratio of 52.69 and a beta of 0.92. The company has a quick ratio of 1.94, a current ratio of 6.31 and a debt-to-equity ratio of 1.10.

Insider Activity

In related news, insider Sarah Duncan bought 5,522 shares of the business’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was bought at an average cost of GBX 71 per share, for a total transaction of £3,920.62. Corporate insiders own 4.88% of the company’s stock.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.